phase 2_initiation
saveThe National Institute of Diabetes and Digestive and Kidney Diseases — thioctic acid (Phase II Trial Initiation)
community read0 votes
Therapy area: Metabolic Disorders. Indication: Insulin Resistance, Obesity
Data sources
globaldata
Found something off?
same company · ±60 days · 2
- phase 1 2 initiationEBTATE: The National Institute of Diabetes and Digestive and Kidney Diseases — EBTATE (Phase I/II Trial Initiation)Apr 27, 2026
- phase 2 completionundisclosed anti-diuretics: The National Institute of Diabetes and Digestive and Kidney Diseases — undisclosed anti-diuretics (Phase II Trial Completion)Apr 30, 2026
🐶 often sniffed alongside
top 8- drugObesity1 co-mentions · 1 sources
- druginsulin1 co-mentions · 1 sources
- companyThe National Institute of Diabetes and Digestive and Kidney Diseases1 co-mentions · 1 sources
- tagEndocrinology & Metabolism1 co-mentions · 1 sources
- tagGastroenterology1 co-mentions · 1 sources
- tagNephrology1 co-mentions · 1 sources
- tagType 2 Diabetes1 co-mentions · 1 sources
- tagObesity1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that